BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29114006)

  • 1. Hyperkalemia across the Continuum of Kidney Function.
    Palmer BF; Clegg DJ
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):155-157. PubMed ID: 29114006
    [No Abstract]   [Full Text] [Related]  

  • 2. Licorice: a sweet alternative to prevent hyperkalemia in dialysis patients?
    Ferrari P
    Kidney Int; 2009 Oct; 76(8):811-2. PubMed ID: 19789539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycyrrhetinic acid food supplementation lowers serum potassium concentration in chronic hemodialysis patients.
    Farese S; Kruse A; Pasch A; Dick B; Frey BM; Uehlinger DE; Frey FJ
    Kidney Int; 2009 Oct; 76(8):877-84. PubMed ID: 19641483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extreme intraoperative hyperkalemia in a non dialysis patient undergoing kidney transplantation.
    Kazanjian M; Neustein SM
    Middle East J Anaesthesiol; 2011 Oct; 21(3):425-6. PubMed ID: 22428502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Not Available].
    Lüthi L; Kistler A; Nowak A
    Praxis (Bern 1994); 2017; 106(11):561-570. PubMed ID: 28537111
    [No Abstract]   [Full Text] [Related]  

  • 6. Electrolyte Disorders in Kidney Transplantation.
    Miles CD; Westphal SG
    Clin J Am Soc Nephrol; 2020 Mar; 15(3):412-414. PubMed ID: 32066594
    [No Abstract]   [Full Text] [Related]  

  • 7. Kidney Function and Potassium Monitoring After Initiation of Renin-Angiotensin-Aldosterone System Blockade Therapy and Outcomes in 2 North American Populations.
    Parikh RV; Nash DM; Brimble KS; Markle-Reid M; Tan TC; McArthur E; Khoshniat-Rad F; Sood MM; Zheng S; Pravoverov L; Nesrallah GE; Garg AX; Go AS
    Circ Cardiovasc Qual Outcomes; 2020 Sep; 13(9):e006415. PubMed ID: 32873054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum potassium in stage 5 CKD patients on their first presentation in a dialysis service of a county hospital in western Romania.
    Gluhovschi G; Mateş A; Gluhovschi C; Golea O; Gădălean F; Somai M; Ene I; Petrica L; Velciov S
    Rom J Intern Med; 2014; 52(1):30-8. PubMed ID: 25000676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Timing and dose in renal replacement therapy].
    Nalesso F; Giuliani A; Basso F; Brendolan A; Ronco C
    Cir Cir; 2013; 81(3):177-80. PubMed ID: 23769244
    [No Abstract]   [Full Text] [Related]  

  • 10. Recovery of Renal Function in a Kidney Transplant Patient After Receiving Hemodialysis for 4 Months.
    Tsai JL; Tsai SF
    Exp Clin Transplant; 2020 Feb; 18(1):112-115. PubMed ID: 30066627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal functional reserve: time to find a new bottle for the old wine?
    Koratala A
    Clin Exp Nephrol; 2018 Apr; 22(2):486-487. PubMed ID: 28913562
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal function and outcome after heart transplantation.
    Kolsrud O; Karason K; Holmberg E; Ricksten SE; Felldin M; Samuelsson O; Dellgren G
    J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1593-1604.e1. PubMed ID: 29338859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical and dialytic management of hyperkalemia in hemodialysis patients.
    Allon M
    Int J Artif Organs; 1996 Dec; 19(12):697-9. PubMed ID: 9029244
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of Renin-Angiotensin Aldosterone System Inhibition on Serum Potassium Levels among Peritoneal Dialysis Patients.
    Ribeiro SC; Figueiredo AE; Barretti P; Pecoits-Filho R; de Moraes TP;
    Am J Nephrol; 2017; 46(2):150-155. PubMed ID: 28738355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldosterone blockade and the mineralocorticoid receptor in the management of chronic kidney disease: current concepts and emerging treatment paradigms.
    Shavit L; Lifschitz MD; Epstein M
    Kidney Int; 2012 May; 81(10):955-968. PubMed ID: 22336987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of aldosterone blockade in resistant hypertension associated with chronic kidney disease.
    Pisoni R; Acelajado MC; Cartmill FR; Dudenbostel T; Dell'Italia LJ; Cofield SS; Oparil S; Calhoun DA
    J Hum Hypertens; 2012 Aug; 26(8):502-6. PubMed ID: 21677673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperkalemia After Initiating Renin-Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project.
    Bandak G; Sang Y; Gasparini A; Chang AR; Ballew SH; Evans M; Arnlov J; Lund LH; Inker LA; Coresh J; Carrero JJ; Grams ME
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28724651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal failure.
    Papper S
    Med Clin North Am; 1971 Mar; 55(2):335-57. PubMed ID: 4993743
    [No Abstract]   [Full Text] [Related]  

  • 19. [Potassium in renal disease].
    Lenz T; Becker B; Bergner R
    Med Klin (Munich); 2004 Jul; 99(7):355-61. PubMed ID: 15322714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of Hyperkalemia in End Stage Renal Disease.
    Akbar SR; Ahmed US; Iqbal HI
    W V Med J; 2016; 112(6):34-8. PubMed ID: 29368827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.